To verify these findings in the clinic, we analyzed the mRNA expression of BCL2 in seven APL primary mononuclear cell cultures collected from leukemia patients at disease presentation by quantitative RT-PCR (qRT-PCR). This evidence concerns the gene BCL2 and leukemia.